The largest database of trusted experimental protocols

Hamster igg isotype control

Manufactured by BioXCell

The Hamster IgG isotype control is a laboratory reagent used in immunological studies. It serves as a control to establish baseline signals and ensure the specificity of antibody-based experiments. The product is derived from hamster immunoglobulin G (IgG), providing a reference point for researchers to evaluate their experimental data.

Automatically generated - may contain errors

3 protocols using hamster igg isotype control

1

Blocking SIGNR1, G-CSF, and Histones

Check if the same lab product or an alternative is used in the 5 most similar protocols
SIGNR1 blocking was performed with intraperitoneal injections of 100 μg anti-SIGNR1 Ab (BioXCell) or hamster IgG isotype control (BioXCell) 1 day before infection followed by intraperitoneal injections (100 μg/mouse) every other day. G-CSF neutralization was achieved with intraperitoneal injections of 100 μg a-G-CSF (eBioscience) or IgG2a isotype control (eBioscience) started 1–2 days post-infection and performed every day until termination of the experiment. Histone neutralisation experiments were performed via intraperitoneal injections with dialysed and combined a-Histone 3 and a-Histone 4 antibodies (Merck Millipore) or control polyclonal rabbit IgG (BioXCell), starting on D-1 (200 μg/mouse) and daily afterwards (200 μg H3 and 100 μg H4).
+ Open protocol
+ Expand
2

Quantifying NK Cell-Mediated Rejection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphoma cells expressing MHC class-I (RMA) were labeled with a high CFSE concentration (6 μM), whereas those with defective expression of MHC class-I (RMAS) were labeled with a low CFSE concentration (0.3 μM). The cells were mixed in a 1:1 ratio (1 × 106 cells per cell type) and injected i.p. into C57BL/6J mice for 12 h. To deplete the NK cells, i.p. injections of rabbit anti-NK1.1 (200 μl) or hamster IgG isotype control (Bio X Cell, Cat. Number: 2A3) were performed before injection of CFSE-stained RMA and RMAS cells. Rejection of NK cell-sensitive RMAS relative to NK cell-resistant RMA cells in the peritoneal cavity was calculated as follows: ([CFSE high] control - [CFSE high] experimental group) × 100%.
+ Open protocol
+ Expand
3

Combination Therapy for Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice were inoculated subcutaneously on their right flank with 2 × 106 Lewis lung cells on day 1, and the mice were subsequently randomly separated into groups. After mice developed palpable tumors, mice were i.g. injected with CF (50 mg/kg) or vehicle-injected daily and started on either 0.2 mg anti-PD1 (Bio X cell, Cat. Number: RPM1-14) or hamster IgG isotype control (Bio X cell, Cat. Number: 2A3) every three days intraperitoneally. The mice were sacrificed on day 19 after implantation, and then tumors were excised, weighed, and photographed. The spleen was isolated to prepare splenocytes. Tumor growth was measured by caliper measurements, tumor volume was calculated using the following formula: V = 1/2 × a × b2, where V = tumor volume, a = maximum tumor diameter, and b= minimum tumor diameter.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!